Acute and Chronic Abnormal Uterine Bleeding Market Insights, Global Outlook and Forecast 2022-2028
Acute and Chronic Abnormal Uterine Bleeding Market Insights, Global Outlook and Forecast 2022-2028
The Acute and Chronic Abnormal Uterine Bleeding Market report highlights technological advancements, investment opportunities, and regulatory frameworks shaping the industry landscape through 2030.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Abnormal uterine bleeding (AUB) may be acute or chronic and is defined as bleeding from the uterine corpus that is abnormal in regularity, volume, frequency, or duration and occurs in the absence of pregnancy.
The latest research study released by Market IntelliX evaluates market size and forecasts of Acute and Chronic Abnormal Uterine Bleeding in Global, including the following market information:
Global Acute and Chronic Abnormal Uterine Bleeding Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Acute and Chronic Abnormal Uterine Bleeding market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Hormonal Treatment Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Acute and Chronic Abnormal Uterine Bleeding include BD, Cook Medical, Teleflex, Utah Medical Products, Kentec Medical, Glenveigh Medical and Clinical Innovations, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Acute and Chronic Abnormal Uterine Bleeding companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Acute and Chronic Abnormal Uterine Bleeding Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Acute and Chronic Abnormal Uterine Bleeding Market Segment Percentages, by Type, 2021 (%)
Hormonal Treatment
Non-hormonal Treatment
Global Acute and Chronic Abnormal Uterine Bleeding Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Acute and Chronic Abnormal Uterine Bleeding Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Other
Global Acute and Chronic Abnormal Uterine Bleeding Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Acute and Chronic Abnormal Uterine Bleeding Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Acute and Chronic Abnormal Uterine Bleeding revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Acute and Chronic Abnormal Uterine Bleeding revenues share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
BD
Cook Medical
Teleflex
Utah Medical Products
Kentec Medical
Glenveigh Medical
Clinical Innovations
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Acute and Chronic Abnormal Uterine Bleeding Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Acute and Chronic Abnormal Uterine Bleeding Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Acute and Chronic Abnormal Uterine Bleeding Overall Market Size
2.1 Global Acute and Chronic Abnormal Uterine Bleeding Market Size: 2021 VS 2028
2.2 Global Acute and Chronic Abnormal Uterine Bleeding Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Acute and Chronic Abnormal Uterine Bleeding Players in Global Market
3.2 Top Global Acute and Chronic Abnormal Uterine Bleeding Companies Ranked by Revenue
3.3 Global Acute and Chronic Abnormal Uterine Bleeding Revenue by Companies
3.4 Top 3 and Top 5 Acute and Chronic Abnormal Uterine Bleeding Companies in Global Market, by Revenue in 2021
3.5 Global Companies Acute and Chronic Abnormal Uterine Bleeding Product Type
3.6 Tier 1, Tier 2 and Tier 3 Acute and Chronic Abnormal Uterine Bleeding Players in Global Market
3.6.1 List of Global Tier 1 Acute and Chronic Abnormal Uterine Bleeding Companies
3.6.2 List of Global Tier 2 and Tier 3 Acute and Chronic Abnormal Uterine Bleeding Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Acute and Chronic Abnormal Uterine Bleeding Market Size Markets, 2021 & 2028
4.1.2 Hormonal Treatment
4.1.3 Non-hormonal Treatment
4.2 By Type - Global Acute and Chronic Abnormal Uterine Bleeding Revenue & Forecasts
4.2.1 By Type - Global Acute and Chronic Abnormal Uterine Bleeding Revenue, 2017-2022
4.2.2 By Type - Global Acute and Chronic Abnormal Uterine Bleeding Revenue, 2023-2028
4.2.3 By Type - Global Acute and Chronic Abnormal Uterine Bleeding Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Acute and Chronic Abnormal Uterine Bleeding Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Other
5.2 By Application - Global Acute and Chronic Abnormal Uterine Bleeding Revenue & Forecasts
5.2.1 By Application - Global Acute and Chronic Abnormal Uterine Bleeding Revenue, 2017-2022
5.2.2 By Application - Global Acute and Chronic Abnormal Uterine Bleeding Revenue, 2023-2028
5.2.3 By Application - Global Acute and Chronic Abnormal Uterine Bleeding Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Acute and Chronic Abnormal Uterine Bleeding Market Size, 2021 & 2028
6.2 By Region - Global Acute and Chronic Abnormal Uterine Bleeding Revenue & Forecasts
6.2.1 By Region - Global Acute and Chronic Abnormal Uterine Bleeding Revenue, 2017-2022
6.2.2 By Region - Global Acute and Chronic Abnormal Uterine Bleeding Revenue, 2023-2028
6.2.3 By Region - Global Acute and Chronic Abnormal Uterine Bleeding Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Acute and Chronic Abnormal Uterine Bleeding Revenue, 2017-2028
6.3.2 US Acute and Chronic Abnormal Uterine Bleeding Market Size, 2017-2028
6.3.3 Canada Acute and Chronic Abnormal Uterine Bleeding Market Size, 2017-2028
6.3.4 Mexico Acute and Chronic Abnormal Uterine Bleeding Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Acute and Chronic Abnormal Uterine Bleeding Revenue, 2017-2028
6.4.2 Germany Acute and Chronic Abnormal Uterine Bleeding Market Size, 2017-2028
6.4.3 France Acute and Chronic Abnormal Uterine Bleeding Market Size, 2017-2028
6.4.4 U.K. Acute and Chronic Abnormal Uterine Bleeding Market Size, 2017-2028
6.4.5 Italy Acute and Chronic Abnormal Uterine Bleeding Market Size, 2017-2028
6.4.6 Russia Acute and Chronic Abnormal Uterine Bleeding Market Size, 2017-2028
6.4.7 Nordic Countries Acute and Chronic Abnormal Uterine Bleeding Market Size, 2017-2028
6.4.8 Benelux Acute and Chronic Abnormal Uterine Bleeding Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Acute and Chronic Abnormal Uterine Bleeding Revenue, 2017-2028
6.5.2 China Acute and Chronic Abnormal Uterine Bleeding Market Size, 2017-2028
6.5.3 Japan Acute and Chronic Abnormal Uterine Bleeding Market Size, 2017-2028
6.5.4 South Korea Acute and Chronic Abnormal Uterine Bleeding Market Size, 2017-2028
6.5.5 Southeast Asia Acute and Chronic Abnormal Uterine Bleeding Market Size, 2017-2028
6.5.6 India Acute and Chronic Abnormal Uterine Bleeding Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Acute and Chronic Abnormal Uterine Bleeding Revenue, 2017-2028
6.6.2 Brazil Acute and Chronic Abnormal Uterine Bleeding Market Size, 2017-2028
6.6.3 Argentina Acute and Chronic Abnormal Uterine Bleeding Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Acute and Chronic Abnormal Uterine Bleeding Revenue, 2017-2028
6.7.2 Turkey Acute and Chronic Abnormal Uterine Bleeding Market Size, 2017-2028
6.7.3 Israel Acute and Chronic Abnormal Uterine Bleeding Market Size, 2017-2028
6.7.4 Saudi Arabia Acute and Chronic Abnormal Uterine Bleeding Market Size, 2017-2028
6.7.5 UAE Acute and Chronic Abnormal Uterine Bleeding Market Size, 2017-2028
7 Players Profiles
7.1 BD
7.1.1 BD Corporate Summary
7.1.2 BD Business Overview
7.1.3 BD Acute and Chronic Abnormal Uterine Bleeding Major Product Offerings
7.1.4 BD Acute and Chronic Abnormal Uterine Bleeding Revenue in Global Market (2017-2022)
7.1.5 BD Key News
7.2 Cook Medical
7.2.1 Cook Medical Corporate Summary
7.2.2 Cook Medical Business Overview
7.2.3 Cook Medical Acute and Chronic Abnormal Uterine Bleeding Major Product Offerings
7.2.4 Cook Medical Acute and Chronic Abnormal Uterine Bleeding Revenue in Global Market (2017-2022)
7.2.5 Cook Medical Key News
7.3 Teleflex
7.3.1 Teleflex Corporate Summary
7.3.2 Teleflex Business Overview
7.3.3 Teleflex Acute and Chronic Abnormal Uterine Bleeding Major Product Offerings
7.3.4 Teleflex Acute and Chronic Abnormal Uterine Bleeding Revenue in Global Market (2017-2022)
7.3.5 Teleflex Key News
7.4 Utah Medical Products
7.4.1 Utah Medical Products Corporate Summary
7.4.2 Utah Medical Products Business Overview
7.4.3 Utah Medical Products Acute and Chronic Abnormal Uterine Bleeding Major Product Offerings
7.4.4 Utah Medical Products Acute and Chronic Abnormal Uterine Bleeding Revenue in Global Market (2017-2022)
7.4.5 Utah Medical Products Key News
7.5 Kentec Medical
7.5.1 Kentec Medical Corporate Summary
7.5.2 Kentec Medical Business Overview
7.5.3 Kentec Medical Acute and Chronic Abnormal Uterine Bleeding Major Product Offerings
7.5.4 Kentec Medical Acute and Chronic Abnormal Uterine Bleeding Revenue in Global Market (2017-2022)
7.5.5 Kentec Medical Key News
7.6 Glenveigh Medical
7.6.1 Glenveigh Medical Corporate Summary
7.6.2 Glenveigh Medical Business Overview
7.6.3 Glenveigh Medical Acute and Chronic Abnormal Uterine Bleeding Major Product Offerings
7.6.4 Glenveigh Medical Acute and Chronic Abnormal Uterine Bleeding Revenue in Global Market (2017-2022)
7.6.5 Glenveigh Medical Key News
7.7 Clinical Innovations
7.7.1 Clinical Innovations Corporate Summary
7.7.2 Clinical Innovations Business Overview
7.7.3 Clinical Innovations Acute and Chronic Abnormal Uterine Bleeding Major Product Offerings
7.7.4 Clinical Innovations Acute and Chronic Abnormal Uterine Bleeding Revenue in Global Market (2017-2022)
7.7.5 Clinical Innovations Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Research Methodology:
Acute and Chronic Abnormal Uterine Bleeding Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|